ClinicalTrials.gg
CompletedNCT05221476Updated Nov 25, 2024

Red Blood Cell Distribution Width and Charlson Comorbidity Indeces in the Frail Polytraumatized Patient.

An observational study in Polytrauma, Red Blood Cell Distribution Width and Comorbidities and Coexisting Conditions, sponsored by Medical University of Vienna. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-11-25.

Sponsored by Medical University of Vienna · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
400
Ages
18 Years and older
Sex
All
01

Study summary

In this study patients who were admitted to our hospital with critical injuries were enrolled retrospectively from January 2012 to December 2015. Patients with an ISS>16 points, an AIS >3 in one body region and at least 2 different body regions affected were included. RDW values on admission as well as preexisting comorbidities were evaluated.

02

Conditions studied

  • Polytrauma
  • Red Blood Cell Distribution Width
  • Comorbidities and Coexisting Conditions

Browse trials for

03

In context

Multiple Trauma

139 studies on the registry are indexed under Multiple Trauma; 32 are open to participants now.

This study's enrollment of 400 is above the median of 200 across 84 observational studies indexed under Multiple Trauma.

Browse Multiple Trauma studies →

Lead sponsor

Medical University of Vienna is the lead sponsor of 1,109 studies on the registry; 184 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Retrospective analysis of polytraumatized patients.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ISS >16 points
  • AIS >3 in one body region
  • at least 2 body regions affected

Exclusion criteria

Exclusion Criteria:

  • patients younger than 18 years of age
  • isolated traumatic brain injury
  • minor injuries (AIS \<3 or ISS \<16 points)
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
400 participants (actual)
Patient registry
No

Groups and cohorts

  • polytraumatized patients

    Patients with an ISS \>16 points, an AIS \>3 in one body region and at least 2 different body regions affected were included.

    Other: retrospective

Interventions

  • Otherretrospective

    The investigators retrospectively analyzed the short- and long-term outcome in polytraumatized patients and the possible influence of RDW values on admission as well as preexisting comorbidities on these outcomes.

06

What researchers measure

Primary outcomes

  1. In-hospital mortality in polytraumatized patients

    Time frame: January 2012 to December 2015

Secondary outcomes

  1. Possible influence of RDW values (%) on admission on the long-term outcome

    The influence of RDW Values (%) in polytraumatized patients on admission on the long-term outcome (late-phase death (days)) will be examined.

    Time frame: January 2012 to December 2015

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 25, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05221476
Responsible party
Dr. Valerie Weihs (MD, Medical University of Vienna) — Principal investigator
First posted
Feb 3, 2022
Start date
Jan 2012
Primary completion
Dec 2015
Completion
Dec 2015
Last update
Nov 25, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion